AKT2 Antikörper
Kurzübersicht für AKT2 Antikörper (ABIN1496565)
Target
Alle AKT2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Human AKT2
-
Aufreinigung
- Protein A/G purified
-
Immunogen
-
Full length human recombinant protein of human AKT2 (NP_001617) produced in HEK293T cell.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Approved: Flo (1:100), IP, WB (1:2000)
Usage: Concentration: 0.5-1.0 mg/mL (Lot dependent) -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
-
Andere Bezeichnung
- AKT2
-
Hintergrund
-
Name/Gene ID: AKT2
Subfamily: RAC/AKT
Family: Protein Kinase
Synonyms: AKT2, PKB beta, PKBBETA, PRKBB, Protein kinase Akt-2, Protein kinase B beta, RAC-PK-beta, Rac protein kinase beta, RAC-BETA, HIHGHH, PKBB -
Gen-ID
- 208
-
NCBI Accession
- NP_001617
-
UniProt
- P31751
-
Pathways
- PI3K-Akt Signalweg, RTK Signalweg, AMPK Signaling, TLR Signalweg, Cellular Glucan Metabolic Process, Regulation of Carbohydrate Metabolic Process, Hepatitis C, VEGF Signaling
Target
-